Literature DB >> 24692623

Non-surgical functional treatment for displaced olecranon fractures in the elderly.

G L Gallucci1, N S Piuzzi, P A I Slullitel, J G Boretto, V A Alfie, A Donndorff, P De Carli.   

Abstract

We retrospectively evaluated the clinical and radiological outcomes of a consecutive cohort of patients aged > 70 years with a displaced fracture of the olecranon, which was treated non-operatively with early mobilisation. We identified 28 such patients (27 women) with a mean age of 82 years (71 to 91). The elbow was initially immobilised in an above elbow cast in 90° of flexion of the elbow for a mean of five days. The cast was then replaced by a sling. Active mobilisation was encouraged as tolerated. No formal rehabilitation was undertaken. At a mean follow-up of 16 months (12 to 26), the mean ranges of flexion and extension were 140° and 15° respectively. On a visual analogue scale of 1 (no pain) to 10, the mean pain score was 1 (0 to 8). Of the original 28 patients 22 developed nonunion, but no patients required surgical treatment. We conclude that non-operative functional treatment of displaced olecranon fractures in the elderly gives good results and a high rate of satisfaction.

Entities:  

Keywords:  Conservative; Elbow fracture; Elderly patients; Functional treatment; Non-surgical treatment; Olecranon fracture

Mesh:

Year:  2014        PMID: 24692623     DOI: 10.1302/0301-620X.96B4.33339

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  12 in total

1.  [Olecranon fractures].

Authors:  M Hackl; V Rausch; C Ries; L P Müller; K Wegmann
Journal:  Unfallchirurg       Date:  2018-11       Impact factor: 1.000

2.  Pilot report: non-operative treatment of Mayo Type II olecranon fractures in any-age adult patient.

Authors:  Matthew D Putnam; Christy M Christophersen; Julie E Adams
Journal:  Shoulder Elbow       Date:  2017-06-05

3.  Complications and mortality associated with olecranon fractures in the elderly: a retrospective cohort comparison from a large level one trauma centre.

Authors:  J Parkes; R Limb; S T Quadri; J N Lamb; G Mohrir; A Yousef; R M West; P Cowling
Journal:  Shoulder Elbow       Date:  2021-03-02

4.  Nonoperative Management of Olecranon Fractures in Elderly Patients: A Systematic Review.

Authors:  Christina A Alvara; Griffin Biedron; John C Dunn
Journal:  Hand (N Y)       Date:  2020-10-14

Review 5.  Olecranon fractures in the elderly during the COVID-19 pandemic: Is non-operative treatment reasonable? Review of the current evidence.

Authors:  Amir Abdelmalek; Mark Crowther
Journal:  Musculoskelet Surg       Date:  2021-01-29

6.  Outcomes of nonoperative management of displaced olecranon fractures in medically unwell patients.

Authors:  William R Aibinder; Laura A Sims; George S Athwal; Graham J W King; Kenneth J Faber
Journal:  JSES Int       Date:  2021-01-10

7.  Locked plating of geriatric olecranon fractures leads to low fixation failure and acceptable complication rates.

Authors:  Kelsey L Wise; Sarah Peck; Lauren Smith; Chad Myeroff
Journal:  JSES Int       Date:  2021-04-16

8.  SOFIE: Surgery for Olecranon Fractures in the Elderly: a randomised controlled trial of operative versus non-operative treatment.

Authors:  Michael Symes; Ian A Harris; John Limbers; Mithun Joshi
Journal:  BMC Musculoskelet Disord       Date:  2015-10-27       Impact factor: 2.362

9.  Trends in Management of Radial Head and Olecranon Fractures.

Authors:  Matthew Motisi; Jennifer Kurowicki; Derek D Berglund; Jacob J Triplet; Shanell Disla; Timothy Niedzielak; Jonathan C Levy
Journal:  Open Orthop J       Date:  2017-03-31

10.  Scandinavian Olecranon Research in the Elderly (SCORE): protocol for a non-inferiority, randomised, controlled, multicentre trial comparing operative and conservative treatment of olecranon fractures in the elderly.

Authors:  Ida Rantalaiho; Inari Laaksonen; Antti P Launonen; Toni Luokkala; Tapio Flinkkilä; Mikko Salmela; L Adolfsson; Bo Olsen; Kari Isotalo; Anssi Ryösä; Ville Äärimaa
Journal:  BMJ Open       Date:  2022-01-31       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.